SCHEMBL22089634

SCHEMBL22089634

COc1cnc(Nc2c(C)cncc2[N+](=O)[O-])nc1C#N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 4/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ PTK2 Q05397 2/20 0.34
▸ PLK1 P53350 4/20 0.34
▸ FGFR1 P11362 3/20 0.33
▸ FGFR3 P22607 3/20 0.33
▸ FGFR2 P21802 2/20 0.33
▸ FGFR4 P22455 2/20 0.33
▸ LRRK2 Q5S007 2/20 0.33
▸ AGTR1 P30556 1/20 0.33
▸ RPS6KB2 Q9UBS0 1/20 0.33
▸ EGFR P00533 1/20 0.33
▸ ERBB2 P04626 1/20 0.33
▸ CHEK1 O14757 2/20 0.33
▸ CDK2 P24941 2/20 0.33
▸ CDC7 O00311 1/20 0.33
▸ PLK4 O00444 1/20 0.33
▸ DCLK1 O15075 1/20 0.33
▸ CHUK O15111 1/20 0.33
▸ PDPK1 O15530 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22089989 0.86 PTK2 (0.39) MAPK1ALDH1A1PTK2PLK1FGFR1
SCHEMBL22090143 0.84 MEN1 (0.35) MAPK1ALDH1A1CDK2CDK1GSK3A
SCHEMBL22090032 0.70 KCNMA1 (0.44) ALDH1A1CDK2LCKCDK1GSK3B
SCHEMBL21198864 0.63 MAPT (0.44) ALDH1A1AGTR1EGFRCHEK1MAPK8
SCHEMBL3559372 0.62 ALDH1A1 (0.44) MAPK1ALDH1A1HTTGAA
SCHEMBL22120118 0.61 GRIA1 (0.42) ALDH1A1HTT
SCHEMBL30142224 0.61 GRIA1 (0.42) ALDH1A1HTT
SCHEMBL17372668 0.61 USP8 (0.44) ALDH1A1AGTR1HTTLMNA
SCHEMBL3173410 0.60 HTT (0.45) ALDH1A1EGFRERBB2CHEK1HTT
SCHEMBL23314963 0.60 FGFR4 (0.52) MAPK1ALDH1A1FGFR1FGFR3FGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020119606-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR GUANGDONG NEWOPP BIOPHARMACEUTICALS CO., LTD. (CN) 2020-06-18 — — WO disclosed
Send feedback